Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene

Human Mutation

Volumn 29, Issue 1, 2008, Pages 22-32

  Lemos, Manuel C ^a,b   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

FIHP; Germline; MEN1; Multiple endocrine neoplasia type 1; Somatic mutation; Tumor

Indexed keywords

METHIONINE;

ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENOTYPE PHENOTYPE CORRELATION; GERM LINE GENE THERAPY; HUMAN; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION RATE; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION;

ANIMALS; ENDOCRINE GLAND NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HUMANS; MICE; MODELS, ANIMAL; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; PARATHYROID NEOPLASMS; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 38149112594     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20605     Document Type: Article

References (121)

1. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Green JS, Guru SC, Manickam P, Olufemi SE, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. 1997. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6:1169-1175.
2. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL. 1999. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96:143-152.
3. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ. 2005. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res 37:369-374.
4. Balogh K, Racz K, Patocs A, Hunyady L. 2006. Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metab 17:357-364.
5. Baralle D, Baralle M. 2005. Splicing in action: assessing disease causing sequence changes. J Med Genet 42:737-748.
6. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH, Thakker RV. 1998. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62:232-244.
7. Bassett JH, Rashbass P, Harding B, Forbes SA, Pannett AA, Thakker RV. 1999. Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, Men1. J Bone Miner Res 14:3-10.
8. Benson L, Ljunghall S, Akerstrom G, Oberg K. 1987. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 82:731-737.
9. Bergman L, Teh B, Cardinal J, Palmer J, Walters M, Shepherd J, Cameron D, Hayward N. 2000. Identification of MEN1 gene mutations in families with MEN 1 and related disorders. Br J Cancer 83:1009-1014.
10. Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. 2003a. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 17:1880-1892.
11. Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ, Zhang CX. 2003b. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech Dev 120:549-560.
12. Boni R, Vortmeyer AO, Pack S, Park WS, Burg G, Hofbauer G, Darling T, Liotta L, Zhuang Z. 1998. Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol 111:539-540.
13. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA, Jr, Marx SJ. 2001. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671.
14. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. 1996. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. J Clin Endocrinol Metab 81:2642-2646.
15. Burgess JR, Greenaway TM, Shepherd JJ. 1998. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243:465-470.
16. Burgess JR, Nord B, David R, Greenaway TM, Parameswaran V, Larsson C, Shepherd JJ, Teh BT. 2000. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clin Endocrinol (Oxf) 53:205-211.
17. Busygina V, Kottemann MC, Scott KL, Plon SE, Bale AE. 2006. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66:8397-8403.
18. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M. 1990. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968-1972.
19. Calender A, Giraud S, Cougard P, Chanson P, Lenoir G, Murat A, Hamon P, Proye C. 1995. Multiple endocrine neoplasia type 1 in France: clinical and genetic studies. J Intern Med 238:263-268.
20. Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Akerstrom G. 1998. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab 83:2960-2963.
21. Cebrian A, Ruiz-Llorente S, Cascon A, Pollan M, Diez JJ, Pico A, Telleria D, Benitez J, Robledo M. 2003. Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients. J Med Genet 40:e72.
22. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. 1997. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407.
23. Chandrasekharappa SC, Teh BT. 2003. Functional studies of the MEN1 gene. J Intern Med 253:606-615.
24. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS. 2001. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98:1118-1123.
25. Cupisti K, Hoppner W, Dotzenrath C, Simon D, Berndt I, Roher HD, Goretzki PE. 2000. Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest 30:325-329.
26. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR. 1997. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6:2285-2290.
27. den Dunnen JT, Antonarakis SE. 2001. Nomenclature for the description of human sequence variations. Hum Genet 109:121-124.
28. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. 1998. Lethality of multiple endocrine neoplasia type I. World J Surg 22:581-586; discussion 586-587.
29. Dreijerink KM, Mulder KW, Winkler GS, Hoppener JW, Lips CJ, Timmers HT. 2006. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66:4929-4935.
30. European Consortium on MEN1. 1997. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6:1177-1183.
31. Farnebo F, Teh BT, Kytola S, Svensson A, Phelan C, Sandelin K, Thompson NW, Hoog A, Weber G, Farnebo LO, Larsson C. 1998. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83:2627-2630.
32. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, McBride WO, Nakamura Y, Brandi ML. 1989. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213-218.
33. Fujii T, Kawai T, Saito K, Hishima T, Hayashi Y, Imura J, Hironaka M, Hosoya Y, Koike M, Fukayama M. 1999. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathol Int 49:968-973.
34. Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, Garramone M, Weiss C, Bohmann D, Musti AM. 2002. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene 21:6434-6445.
35. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delemer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M, Meyrier A, Caron P, Vantyghem MC, Assayag M, Peix JL, Pugeat M, Rohmer V, Vallotton M, Lenoir G, Gaudray P, Proye C, Conte-Devolx B, Chanson P, Shugart YY, Goldgar D, Murat A, Calender A. 1998. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 63:455-467.
36. Gortz B, Roth J, Speel EJ, Krahenmann A, De Krijger RR, Matias-Guiu X, Muletta-Feurer S, Rutmann K, Saremaslani P, Heitz PU, Komminoth P. 1999a. MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80:373-379.
37. Gortz B, Roth J, Krahenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P, Speel EJ, Heitz PU, Komminoth P. 1999b. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 154:429-436.
38. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC. 1998. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95:1630-1634.
39. Hamaguchi K, Nguyen DC, Yanase T, Ikuyama S, Goto K, Takayanagi R, Nawata H, Kusuda Y, Fukagawa K, Sakata T. 1999. Novel germline mutations of the MEN1 gene in Japanese patients with multiple endocrine neoplasia type 1. J Hum Genet 44:43-47.
40. Hao W, Skarulis MC, Simonds WF, Weinstein LS, Agarwal SK, Mateo C, James-Newton L, Hobbs GR, Gibril F, Jensen RT, Marx SJ. 2004. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 89:3776-3784.
41. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. 1997. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16:375-378.
42. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL. 2001. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20:4917-4925.
43. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerstrom G, Westin G. 1998. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 58:377-379.
44. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M. 1989. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J 8:1433-1439.
45. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. 2004. Nonsense-mediated decay approaches the clinic. Nat Genet 36:801-808.
46. Huang SC, Zhuang Z, Weil RJ, Pack S, Wang C, Krutzsch HC, Pham TA, Lubensky IA. 1999. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab Invest 79:301-310.
47. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA, Kay GF, Hayward NK, Hess JL, Meyerson M. 2004. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13:587-597.
48. Hussein N, Casse H, Fontaniere S, Morera AM, Asensio MJ, Bakeli S, Lu JL, Coste I, Di Clemente N, Bertolino P, Zhang CX. 2007. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis. Eur J Cancer 43:402-414.
49. Jager AC, Friis-Hansen L, Hansen TV, Eskildsen PC, Solling K, Knigge U, Hansen CP, Andersen PH, Brixen K, Feldt-Rasmussen U, Kroustrup JP, Mollerup CL, Rehfeld JF, Blichert-Toft M, Nielsen FC. 2006. Characteristics of the Danish families with multiple endocrine neoplasia type 1. Mol Cell Endocrinol 249:123-132.
50. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD, Hua X. 2003. Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63:4204-4210.
51. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN. 2001. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci USA 98:3837-3842.
52. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M, Kim SK. 2005. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102:14659-14664.
53. Khajavi M, Inoue K, Lupski JR. 2006. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074-1081.
54. Khodaei-O'Brien S, Zablewska B, Fromaget M, Bylund L, Weber G, Gaudray P. 2000. Heterogeneity at the 5′-end of MEN1 transcripts. Biochem Biophys Res Commun 276:508-514.
55. Kim YS, Burns AL, Goldsmith PK, Heppner C, Park SY, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ. 1999. Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18:5936-5942.
56. Kim H, Lee JE, Cho EJ, Liu JO, Youn HD. 2003. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 63:6135-6139.
57. Knudson AG, Jr. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
58. Knudson AG, Jr, Strong LC, Anderson DE. 1973. Heredity and cancer in man. Prog Med Genet 9:113-158.
59. Kuzmiak HA, Maquat LE. 2006. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 12:306-316.
60. La P, Silva AC, Hou Z, Wang H, Schnepp RW, Yan N, Shi Y, Hua X. 2004. Direct binding of DNA by tumor suppressor menin. J Biol Chem 279:49045-49054.
61. La P, Desmond A, Hou Z, Silva AC, Schnepp RW, Hua X. 2006. Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene 25:3537-3546.
62. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696.
63. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. 1988. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87.
64. Lemmens IH, Forsberg L, Pannett AA, Meyen E, Piehl F, Turner JJ, Van de Ven WJ, Thakker RV, Larsson C, Kas K. 2001. Menin interacts directly with the homeobox-containing protein Pem. Biochem Biophys Res Commun 286:426-431.
65. Lemos MC, Harding B, Shalet SM, Thakker RV. 2007a. A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 66:709-713.
66. Lemos MC, Harding B, Bowl M, Reed A, Tateossian H, Hough T, Fraser W, Cheeseman M, Thakker RV. 2007b. Mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele develop pancreatic, pituitary and parathyroid tumours in association with hypercalcaemia. Endocrine Abstracts 13:OC22.
67. Lemos MC, Harding B, Thakker RV. 2007c. Genetic background influences expression of multiple endocrine neoplasia type 1 (MEN1) mutation, implicating a role for genetic modifiers. Endocrine Abstracts 13:P199A.
68. Lin SY, Elledge SJ. 2003. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113:881-889.
69. Lips CJ, Vasen HF, Lamers CB. 1984- Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2:117-184.
70. Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK, Kay GF. 2007. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer 120:259-267.
71. Lopez-Egido J, Cunningham J, Berg M, Oberg K, Bongcam-Rudloff E, Gobl A. 2002. Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. Exp Cell Res 278:175-183.
72. Ludwig L, Schleithoff L, Kessler H, Wagner PK, Boehm BO, Karges W. 1999. Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma. Endocr J 46:539-544.
73. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR. 1990. Two G protein oncogenes in human endocrine tumors. Science 249:655-659.
74. Mailman MD, Muscarella P, Schirmer WJ, Ellison EC, O'Dorisio TM, Prior TW. 1999. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue. Clin Chem 45:29-34.
75. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. 1998. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484-494.
76. Miedlich S, Krohn K, Lamesch P, Muller A, Paschke R. 2000. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism. Eur J Endocrinol 143:47-54.
77. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL. 2005. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102:749-754.
78. Nord B, Platz A, Smoczynski K, Kytola S, Robertson G, Calender A, Murat A, Weintraub D, Burgess J, Edwards M, Skogseid B, Owen D, Lassam N, Hogg D, Larsson C, Teh BT. 2000. Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma. Int J Cancer 87:463-467.
79. Ohungu VH, Lee Burns A, Agarwal SK, Chandrasekharapa SC, Adelstein RS, Marx SJ. 2003. Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain. Oncogene 22:6347-6358.
80. Ohkura N, Kishi M, Tsukada T, Yamaguchi K. 2001. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochem Biophys Res Commun 282:1206-1210.
81. Olufemi SE, Green JS, Manickam P, Guru SC, Agarwal SK, Kester MB, Dong Q, Burns AL, Spiegel AM, Marx SJ, Collins FS, Chandrasekharappa SC. 1998. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 11:264-269.
82. Pagani F, Baralle FE. 2004. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5:389-396.
83. Pannett AA, Thakker RV. 1999. Multiple endocrine neoplasia type 1. Endocr Relat Cancer 6:449-473.
84. Pannett AA, Thakker RV. 2001. Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. J Clin Endocrinol Metab 86:4371-4374.
85. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M. 1994. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76:747-760.
86. Prezant TR, Levine J, Melmed S. 1998. Molecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab 83:1388-1391.
87. Ryder K, Lanahan A, Perez-Albuerne E, Nathans D. 1989. jun-D: a third member of the jun gene family. Proc Natl Acad Sci USA 86:1500-1503.
88. Sato K, Yamazaki K, Zhu H, Kanhe M, Iihara M, Wada Y, Tanaka R, Okamoto T, Ito Y, Obara T. 2000. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism. Surgery 127:337-341.
89. Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC, Collins FS. 2001. Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30:259-263.
90. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS, Collins FS. 2006. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2:e51.
91. Schmidt MC, Henke RT, Stangl AP, Meyer-Puttlitz B, Stoffel-Wagner B, Schramm J, von Deimling A. 1999. Analysis of the MEN1 gene in sporadic pituitary adenomas. J Pathol 188:168-173.
92. Schnepp RW, Hou Z, Wang H, Petersen C, Silva A, Masai H, Hua X. 2004. Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res 64:6791-6796.
93. Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoto M, Arima R, Kameya T, Kakudo K. 1998. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 78:471-475.
94. Soares BS, Frohman LA. 2004. Isolated familial somatotropinoma. Pituitary 7:95-101.
95. Soares BS, Eguchi K, Frohman LA. 2005. Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J Clin Endocrinol Metab 90:6580-6587.
96. Sowa H, Kaji H, Canaff L, Hendy GN, Tsukamoto T, Yamaguchi T, Miyazono K, Sugimoto T, Chihara K. 2003. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem 278:21058-21069.
97. Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K. 2004. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 279:40267-40275.
98. Stalberg P, Grimfjard P, Santesson M, Zhou Y, Lindberg D, Gobl A, Oberg K, Westin G, Rastad J, Wang S, Skogseid B. 2004. Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1. J Clin Endocrinol Metab 89:2326-2337.
99. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S, Xian CZ, Khodei S, Teh BT, Lagercrantz J, Siggers P, Calender A, Van de Vem V, Kas K, Weber G, Hayward N, Gaudray P, Larsson C. 1998. Characterization of the mouse Men1 gene and its expression during development. Oncogene 17:2485-2493.
100. Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, Oldfield EH, Marx SJ. 2000. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 85:4776-4780.
101. Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu VH, Novotny EA, Crabtree JS, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. 2003. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 23:493-509.
102. Tanaka C, Kimura T, Yang P, Moritani M, Yamaoka T, Yamada S, Sano T, Yoshimoto K, Itakura M. 1998. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab 83:2631-2634.
103. Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, Tranebjaerg L, Jorde R, Salmela P. 1998. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 83:2621-2626.
104. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM, O'Riordan JL. 1989. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321:218-224.
105. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. 1993. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815-2821.
106. Thakker RV. 1998. Multiple endocrine neoplasia - syndromes of the twentieth century. J Clin Endocrinol Metab 83:2617-2620.
107. Thakker RV. 2006. Endocrine tumor syndromes. In: DeGroot LJ, Jameson JL, editors. Endocrinology. Philadelphia: Elsevier Saunders. p 3509-3531.
108. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV. 1996. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89:653-669.
109. Turner JJ, Leotlela PD, Pannett AA, Forbes SA, Bassett JH, Harding B, Christie PT, Bowen-Jones D, Ellard S, Hattersley A, Jackson CE, Pope R, Quarrell OW, Trembath R, Thakker RV. 2002. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metah 87:2688-2693.
110. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA. 2006. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230.
111. Villablanca A, Wassif WS, Smith T, Hoog A, Vierimaa O, Kassem M, Dwight T, Forsberg L, Du Q, Learoyd D, Jones K, Stranks S, Juhlin C, Teh BT, Carling T, Robinson B, Larsson C. 2002. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. Eur J Endocrinol 147:313-322.
112. Vortmeyer AO, Boni R, Pak E, Pack S, Zhuang Z. 1998. Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. J Natl Cancer Inst 90:398-399.
113. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E, Jr, Sawicki MP. 1998. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 58:4417-4420.
114. Wermer P. 1954. Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363-371.
115. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ. 1993. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 128:683-690.
116. Yaguchi H, Ohkura N, Tsukada T, Yamaguchi K. 2002. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem 277:38197-38204.
117. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitahayashi I, Tsukada T. 2004. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol 24:6569-6580.
118. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, Cleary ML. 2004. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24:5639-5649.
119. Yumita W, Ikeo Y, Yamauchi K, Sakurai A, Hashizume K. 2003. Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction. Int J Cancer 103:738-744.
120. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Lubensky IA. 1997a. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686.
121. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA. 1997b. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446-5451.